Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Palantir Technologies Guides For Full Year 2024 Revenue of $2.742-$2.75 Billion, vs CIQ Analyst Consensus of $2.7 Billion
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Palantir Technologies Guides For Full Year 2024 Revenue of $2.742-$2.75 Billion, vs CIQ Analyst Consensus of $2.7 Billion
Aug 5, 2024 1:58 PM
04:08 PM EDT, 08/05/2024 (MT Newswires) --
Price: 28.00, Change: +3.90, Percent Change: +16.18
Previous page:
China's CATL sees slowest profit growth in six years
Next page:
Tesla in Letter to US Trade Representative's Office Warns About Trade Policy Impacts on Domestic Exporters
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
China's CATL sees slowest profit growth in six years
Mar 14, 2025
BEIJING (Reuters) - CATL reported 15% growth in 2024 net profit, the slowest pace in six years, as a prolonged price war in China's electric vehicle market put pressure on the Chinese EV battery giant. Net profit was up 15% last year to 50.7 billion yuan ($7.01 billion), versus its forecast of 11.1-20.1%, according to a stock filing on Friday....
Tesla in Letter to US Trade Representative's Office Warns About Trade Policy Impacts on Domestic Exporters
Mar 14, 2025
08:30 AM EDT, 03/14/2025 (MT Newswires) -- Tesla (TSLA) in a letter to the US Trade Representative's Office said the US exporters are inherently exposed to disproportionate impacts when other countries retaliate against US trade actions. In the letter, dated Tuesday, Tesla urged the government to consider the downstream effects of trade measures aimed at addressing unfair trade practices. Tesla...
Korro Bio's Potential Antitrypsin Deficiency Treatment Receives US FDA Orphan Drug Designation
Mar 14, 2025
08:38 AM EDT, 03/14/2025 (MT Newswires) -- Korro Bio ( KRRO ) said Friday that the US Food and Drug Administration has granted orphan drug designation to its investigational medicine KRRO-110 for the treatment of alpha-1 antitrypsin deficiency, or AATD. AATD is a genetic disorder that can cause pulmonary emphysema and/or hepatic cirrhosis, Korro Bio ( KRRO ) said. Korro...
Turtle Beach's PDP Acquisition Seen Driving Over $400 Million in Revenue in 2025, Wedbush Says
Mar 14, 2025
08:33 AM EDT, 03/14/2025 (MT Newswires) -- Turtle Beach's ( TBCH ) takeover of Performance Designed Products, or PDP, is going very well and it is expected to generate more than $400 million in total revenue in 2025, Wedbush said in a Friday note. There should be meaningful earnings before interest, taxes, depreciation, and amortization over the next several quarters...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP